OpenVSafe by OpenVAERS
Search V-safe

RSW-24543-26210

2 vaccinations 3 coded responses 8 check-ins 3 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
240 / VA
Registered
2022-06-28
Relationship
Child or adolescent in my care
Guardian
LQP-24596-09277
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-22
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-28
    Registered in v-safe
  3. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-29
    Survey response — day 7, dose 1, under 3
    MedDRA: Sleep disorder — Feeling: Good
    Free text: Changes to sleep cycle, rising earlier
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-07-08
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  6. 2022-07-13
    Dose 2 — Pfizer-BioNTech
  7. 2022-07-27
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  8. 2022-08-03
    Survey response — day 21, dose 2, under 3
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Runny nose.
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-08-17
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-08-26
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-10-13
    Survey response — 3 months, dose 2, under 3
    MedDRA: Gastrointestinal viral infection, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: RSV (still recovering) and a GI virus
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-10-13
    Report sent to call center — 3 months, dose 2, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  13. 2022-10-14
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12022-06-22Pfizer-BioNTech No
22022-07-13Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 7, dose 1, under 3

2022-06-29

Systemic reaction (other): Changes to sleep cycle, rising earlier

Release 12 (Under 3) — day 21, dose 2, under 3

2022-08-03

Symptoms: Runny nose.

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-13

Symptoms: RSV (still recovering) and a GI virus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGastrointestinal viral infection · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRhinorrhoea · · ✓
SROSleep disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…